Intellia Therapeutics News

Intellia Therapeutics | DEFA14A: Others

Apr 30 04:58

Intellia Therapeutics | DEF 14A: Definitive information statements

Apr 30 04:20

Intellia Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 17 04:18

Intellia Therapeutics | 8-K: Current report

Apr 16 04:26

Intellia Therapeutics | 8-K: Current report

Mar 22 21:27

Intellia Therapeutics | 8-K: Current report

Feb 24 06:21

Intellia Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 23 05:20

Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress

Feb 22 20:46

Intellia Therapeutics | 8-K: Current report

Feb 2 05:09

Intellia Therapeutics | 8-K: Current report

Jan 4 13:00

Intellia Therapeutics | 8-K: Current report

Dec 6, 2023 20:00

Intellia Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Nov 24, 2023 22:30

Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Nov 9, 2023 20:45

Intellia Therapeutics | 8-K: Current report

Nov 2, 2023 19:11

Intellia Therapeutics | 8-K: Current report

Oct 18, 2023 19:30

Intellia Therapeutics | 8-K: Current report

Oct 3, 2023 19:19

Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress

Aug 3, 2023 19:45

Intellia Therapeutics | 8-K: Current report

Jun 17, 2023 04:13

Intellia Therapeutics | 8-K: Current report

Jun 12, 2023 19:00

Intellia Therapeutics | DEFA14A: Others

Jun 6, 2023 05:16